You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial Completed
610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023178014
Dec 20236906
Jan 20244206
Feb 20243401
Mar 20242004
Apr 20242201
May 20242400
Jun 20241800
Jul 20244204
Aug 20241601
Sep 20242402
Oct 20241402
Nov 20243204
Dec 20241805
Jan 20252406
Feb 2025602
Mar 2025004
Apr 2025003
May 2025005
Jun 2025003
Total583073